BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27118257)

  • 1. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
    Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
    Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch Signaling Promotes Development of Allergic Rhinitis by Suppressing Foxp3 Expression and Treg Cell Differentiation.
    Jiao WE; Wei JF; Kong YG; Xu Y; Tao ZZ; Chen SM
    Int Arch Allergy Immunol; 2019; 178(1):33-44. PubMed ID: 30391960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.
    Zhang L; Wang XI; Ding J; Sun Q; Zhang S
    Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.
    Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L
    Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
    Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
    Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher densities of Foxp3
    Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of FOXP3 expression in triple-negative breast cancer.
    Lee S; Cho EY; Park YH; Ahn JS; Im YH
    Acta Oncol; 2013 Jan; 52(1):73-81. PubMed ID: 23075422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of Notch receptors in human hepatocellular carcinoma.
    Gao J; Song Z; Chen Y; Xia L; Wang J; Fan R; Du R; Zhang F; Hong L; Song J; Zou X; Xu H; Zheng G; Liu J; Fan D
    Dig Liver Dis; 2008 Feb; 40(2):114-21. PubMed ID: 17920003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.
    Dell'albani P; Rodolico M; Pellitteri R; Tricarichi E; Torrisi SA; D'Antoni S; Zappia M; Albanese V; Caltabiano R; Platania N; Aronica E; Catania MV
    Neuro Oncol; 2014 Jan; 16(2):204-16. PubMed ID: 24305720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
    Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
    Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.
    de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ
    J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
    Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
    Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
    Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
    Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.
    Blok EJ; van den Bulk J; Dekker-Ensink NG; Derr R; Kanters C; Bastiaannet E; Kroep JR; van de Velde CJ; Kuppen PJ
    Oncotarget; 2017 Feb; 8(9):15610-15620. PubMed ID: 28121628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CD8 and FOXP3 expression in stromal tumor-infiltrating lymphocytes of triple-negative breast carcinomas: a clinicopathologic study].
    Pan BJ; Ping GQ; Zhang WM; Wang C; Li HX; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):540-4. PubMed ID: 27510779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3 expression in CD4
    Zhu XW; Zhu HZ; Zhu YQ; Feng MH; Qi J; Chen ZF
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):677-682. PubMed ID: 27752897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.